Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral Contraceptives.

The article reports on the results of a study of the risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. A description of the experimental setup and measurement method is given. The study concluded that ethinylestradiol/drospirenone initiators and initiators of other oral contraceptives are similarly likely to experience thromboembolism.